Intralesional methotrexate treatment for keratoacanthoma tumors: A retrospective study and review of the literature

Journal of the American Academy of Dermatology

Volumn 56, Issue 6, 2007, Pages 989-993

  Annest, Nicole M ^a   VanBeek, Marta J ^b   Arpey, Christopher J ^b   Whitaker, Duane C ^c  

^a SCRIPPS CLINIC   (United States)

^b UNIVERSITY OF IOWA HOSPITALS AND CLINICS   (United States)

^c UNIVERSITY OF ARIZONA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHOTREXATE;

ADULT; AGED; ARTICLE; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; KERATOACANTHOMA; MALE; MEDICAL LITERATURE; PANCYTOPENIA; PRIORITY JOURNAL; TREATMENT OUTCOME; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; ANTIMETABOLITES, ANTINEOPLASTIC; FEMALE; HUMANS; INJECTIONS; KERATOACANTHOMA; MALE; METHOTREXATE; MIDDLE AGED; RETREATMENT; RETROSPECTIVE STUDIES;

EID: 34248140144     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jaad.2006.12.017     Document Type: Article

References (27)

1. Beham A., Regauer S., Soyer H.P., and Beham-Schmid C. Keratoacanthoma: a clinically distinct variant of well-differentiated squamous cell carcinoma. Adv Anat Pathol 5 (1998) 269-280
2. Manstein C.H., Frauenhoffer C.J., and Besden J.E. Keratoacanthoma: is it a real entity?. Ann Plast Surg 40 (1998) 469-472
3. Benest L., Kaplan R.P., Salit R., and Moy R. Keratoacanthoma centrifugum marginatum of the lower extremity treated with Mohs micrographic surgery. J Am Acad Dermatol 31 (1994) 501-502
4. Larson P.O. Keratoacanthomas treated with Mohs' micrographic surgery (chemosurgery): a review of forty-three cases. J Am Acad Dermatol 16 (1987) 1040-1044
5. Wong W.Y., Kolbusz R.V., Goldberg L.H., and Guana A. Treatment of a recurrent keratoacanthoma with oral isotretinoin. Int J Dermatol 33 (1994) 579-583
6. Goldschmidt H., and Sherwin W.K. Radiation therapy of giant aggressive keratoacanthomas. Arch Dermatol 129 (1993) 1162-1165
7. Caccialanza M., and Sopelana N. Radiation therapy of keratoacanthomas: results in 55 patients. Int J Radiat Oncol Biol Phys 16 (1989) 475-477
8. Reymann F. Treatment of keratoacanthomas with curettage. Dermatologica 155 (1997) 90-96
9. Nedwich J.A. Evaluation of curettage and electrodesiccation in treatment of keratoacanthoma. Australas J Dermatol 32 (1991) 137-141
10. Sheridan A.T., and Dawber R.P. Curettage, electrosurgery and skin cancer. Australas J Dermatol 41 (2000) 19-30
11. Klein E., Milgram H., and Traenkle H.L. Tumors of the skin, II: keratoacanthoma, local effect of 5-fluorouracil (5-FU). Skin 1 (1962) 153-156
12. Bergin D.J., Lapins N.A., and Deffer T.A. Intralesional 5-fluorouracil for keratoacanthoma of the eyelid. Ophthal Plast Reconstr Surg 2 (1986) 201-204
13. Parker C.M., and Hanke C.W. Large keratoacanthomas in difficult locations treated with intralesional 5-fluorouracil. J Am Acad Dermatol 14 (1986) 770-777
14. Thiele J.J., Ziemer M., Fuchs S., and Elsner P. Combined 5-fluorouracil and Er:YAG laser treatment in a case of recurrent giant keratoacanthoma of the lower leg. Dermatol Surg 30 (2004) 1556-1560
15. Melton J.L., Nelson B.R., Stough D.B., Brown M.D., Swanson N.A., and Johnson T.M. Treatment of keratoacanthomas with intralesional methotrexate. J Am Acad Dermatol 25 (1991) 1017-1023
16. Hurst L.N., and Gan B.S. Intralesional methotrexate in keratoacanthoma of the nose. Br J Plast Surg 48 (1995) 243-246
17. Cuesta-Romero C., and de Grado-Pena J. Intralesional methotrexate in solitary keratoacanthoma. Arch Dermatol 134 (1998) 513-514
18. Remling R., Mempel M., Schnopp N., Abeck D., and Ring J. Intralesional methotrexate injection: an effective time and cost saving therapy alternative in keratoacanthomas that are difficult to treat surgically. Hautarzt 51 (2000) 612-614
19. Spieth K., Gille J., and Kaufmann R. Intralesional methotrexate as effective treatment in solitary giant keratoacanthoma of the lower lip. Dermatology 200 (2000) 317-319
20. Richard M.A., Gachon J., Choux R., Laurans R., Folchetti G., and Grob J.J. Treatment of keratoacanthoma with intralesional methotrexate injections. Ann Dermatol Venereol 127 (2000) 1097
21. de Visscher J.G., van der Wal K.G., Blanken R., and Willemse F. Treatment of giant keratoacanthoma of the skin of the lower lip with intralesional methotrexate: a case report. J Oral Maxillofac Surg 60 (2002) 93-95
22. Cohen P.R., Schulze K.E., Teller C.F., and Nelson B.R. Intralesional methotrexate for keratoacanthoma of the nose. Skinmed 4 (2005) 393-395
23. Oh C.K., Son H.S., Lee J.B., Jang H.S., and Kwon K.S. Intralesional interferon alfa-2b treatment of keratoacanthomas. J Am Acad Dermatol 51 (2004) 1040
24. Dendorfer M., Oppel T., Wollenberg A., and Prinz J.C. Topical treatment with imiquimod may induce regression of facial keratoacanthoma. Eur J Dermatol 13 (2003) 80-82
25. Olsen E.A. The pharmacology of methotrexate. J Am Acad Dermatol 25 (1991) 306-318
26. Goebeler M., Lurz C., Kolve-Goebeler M.E., and Brocker E.B. Pancytopenia after treatment of keratoacanthoma by single lesional methotrexate infiltration. Arch Dermatol 137 (2001) 1104-1105
27. Cohen P.R., Schulze K.E., and Nelson B.R. Pancytopenia after a single intradermal infiltration of methotrexate. J Drugs Dermatol 4 (2005) 648-651